OBJECTIVES: Estimates of the use of complementary and alternative medicine (CAM) among cancer survivors vary widely. Dietary supplements are an important CAM therapy to examine because of their potential to interact with conventional cancer therapies. We estimated the prevalence of dietary supplement use in a population-based sample of cancer survivors of the 10 most common cancers and examined potential correlates of use. DESIGN AND SUBJECTS: This cross-sectional analysis included participants from the American Cancer Society's longitudinal Study of Cancer Survivors-I recruited in Connecticut who completed self-administered baseline and supplemental questionnaires. Using univariate and multivariate logistic regression, we examined demographic, clinical, and psychosocial predictors of dietary supplement use after cancer diagnosis. RESULTS: Of the 827 cancer survivors, 573 (69.3%) reported using dietary supplements after their cancer diagnosis. Female gender [odds ratio (OR) = 1.72, 95% confidence interval (CI) = 1.25-2.36] and higher-education levels (OR = 5.44, 95% CI = 2.98-9.93) were significantly associated with supplement use. Common reasons for using dietary supplements included "something they could do to help themselves" (56.2%) and "to boost their immune system" (51.1%). Most survivors (82.4%) informed their physician of their supplement use. Patients obtained information from a variety of sources including physicians, friends or family, and magazines or books. CONCLUSIONS: Use of dietary supplements after cancer diagnosis was quite common among this population-based sample of cancer survivors. Although gender and education were associated with use, it is important that clinicians discuss supplement use with all cancer survivors.
OBJECTIVES: Estimates of the use of complementary and alternative medicine (CAM) among cancer survivors vary widely. Dietary supplements are an important CAM therapy to examine because of their potential to interact with conventional cancer therapies. We estimated the prevalence of dietary supplement use in a population-based sample of cancer survivors of the 10 most common cancers and examined potential correlates of use. DESIGN AND SUBJECTS: This cross-sectional analysis included participants from the American Cancer Society's longitudinal Study of Cancer Survivors-I recruited in Connecticut who completed self-administered baseline and supplemental questionnaires. Using univariate and multivariate logistic regression, we examined demographic, clinical, and psychosocial predictors of dietary supplement use after cancer diagnosis. RESULTS: Of the 827 cancer survivors, 573 (69.3%) reported using dietary supplements after their cancer diagnosis. Female gender [odds ratio (OR) = 1.72, 95% confidence interval (CI) = 1.25-2.36] and higher-education levels (OR = 5.44, 95% CI = 2.98-9.93) were significantly associated with supplement use. Common reasons for using dietary supplements included "something they could do to help themselves" (56.2%) and "to boost their immune system" (51.1%). Most survivors (82.4%) informed their physician of their supplement use. Patients obtained information from a variety of sources including physicians, friends or family, and magazines or books. CONCLUSIONS: Use of dietary supplements after cancer diagnosis was quite common among this population-based sample of cancer survivors. Although gender and education were associated with use, it is important that clinicians discuss supplement use with all cancer survivors.
Authors: Elmer V Bernstam; Muhammad F Walji; Smitha Sagaram; Deepak Sagaram; Craig W Johnson; Funda Meric-Bernstam Journal: Cancer Date: 2008-03-15 Impact factor: 6.860
Authors: O Paltiel; M Avitzour; T Peretz; N Cherny; L Kaduri; R M Pfeffer; N Wagner; V Soskolne Journal: J Clin Oncol Date: 2001-05-01 Impact factor: 44.544
Authors: Ruth E Patterson; Marian L Neuhouser; Monique M Hedderson; Stephen M Schwartz; Leanna J Standish; Deborah J Bowen Journal: J Am Diet Assoc Date: 2003-03
Authors: Ruth E Patterson; Marian L Neuhouser; Monique M Hedderson; Stephen M Schwartz; Leanna J Standish; Deborah J Bowen; Lynn M Marshall Journal: J Altern Complement Med Date: 2002-08 Impact factor: 2.579
Authors: Jessie Satia-Abouta; Alan R Kristal; Ruth E Patterson; Alyson J Littman; Kayla L Stratton; Emily White Journal: Am J Prev Med Date: 2003-01 Impact factor: 5.043
Authors: Jessie A Satia; Marci K Campbell; Joseph A Galanko; Aimee James; Carol Carr; Robert S Sandler Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-06 Impact factor: 4.254
Authors: Regan L Bailey; Kevin W Dodd; Jaime J Gahche; Johanna T Dwyer; Alexandra E Cowan; Shinyoung Jun; Heather A Eicher-Miller; Patricia M Guenther; Anindya Bhadra; Paul R Thomas; Nancy Potischman; Raymond J Carroll; Janet A Tooze Journal: J Nutr Date: 2019-02-01 Impact factor: 4.798
Authors: Heather Greenlee; Alfred I Neugut; Laura Falci; Grace Clarke Hillyer; Donna Buono; Jeanne S Mandelblatt; Janise M Roh; Isaac J Ergas; Marilyn L Kwan; Marion Lee; Wei Yann Tsai; Zaixing Shi; Lois Lamerato; Lawrence H Kushi; Dawn L Hershman Journal: JAMA Oncol Date: 2016-09-01 Impact factor: 31.777
Authors: LeQuyen Luc; Charlotte Baumgart; Edward Weiss; Lesley Georger; Christine B Ambrosone; Gary Zirpoli; Susan E McCann Journal: Public Health Nutr Date: 2014-05-27 Impact factor: 4.022
Authors: Alexandra E Cowan; Shinyoung Jun; Janet A Tooze; Kevin W Dodd; Jaime J Gahche; Heather A Eicher-Miller; Patricia M Guenther; Johanna T Dwyer; Alanna J Moshfegh; Donna G Rhodes; Anindya Bhadra; Regan L Bailey Journal: J Nutr Date: 2020-04-01 Impact factor: 4.798
Authors: Pamela N Klassen; Benjamin A Goldenberg; Pascal Lambert; Kathy Vagianos; Christina A Kim Journal: Support Care Cancer Date: 2020-02-23 Impact factor: 3.603
Authors: Mary Playdon; Leah M Ferrucci; Ruth McCorkle; Kevin D Stein; Rachel Cannady; Tara Sanft; Brenda Cartmel Journal: J Cancer Surviv Date: 2016-01-07 Impact factor: 4.442